XARELTO®, in combination with low-dose aspirin,‡ is the only drug in its class§ indicated to help reduce the risk of heart attack, stroke, or cardiovascular death in adults with CAD.
What is XARELTO®?
XARELTO® belongs to a group of medicines called direct oral anticoagulants, or DOACs for short. Like other DOACs, XARELTO® has no known dietary restrictions and no requirements for frequent blood tests.
XARELTO®, in combination with low-dose aspirin,‡ is the only drug in its class§ indicated to help reduce the risk of heart attack, stroke, or cardiovascular death in adults with CAD.
In fact, in a clinical trial, almost 96% of adults with CAD taking XARELTO® 2.5 mg twice daily, in combination with low-dose aspirin, did not have a heart attack, stroke, or die from a cardiovascular event.||
Remember, all blood thinners come with a risk of bleeding. Around 3% of people taking XARELTO® 2.5 mg twice daily in combination with low-dose aspirin experienced a major bleeding event, such as bleeding into the brain, compared to around 2% of people taking low-dose aspirin alone.
‡Low-dose aspirin = 75 mg–100 mg once daily.
§Direct Oral Anticoagulant (DOAC).
||The rate of the first event like a stroke, heart attack, or cardiovascular death was 4.2% for people taking XARELTO® plus aspirin vs 5.6% for aspirin alone. Patients were followed for an average of 23 months.
Take one XARELTO® 2.5 mg tablet twice daily with or without food in combination with low-dose aspirin (75 mg-100 mg) once daily
![]()
Tablets shown not actual size
How do you take XARELTO®?
Are there any side effects associated with XARELTO® in adults?
Side effects of XARELTO®:
Your risk of bleeding increases if you take XARELTO® with other medicines that also increase your risk of bleeding, such as:

Getting started with XARELTO®?
Discover information about getting started with XARELTO®, savings options, and your condition—all in one helpful starter kit.